Shree Ganesh Biotech (India) Ltd

Company Profile

Shree Ganesh Biotech (India) Ltd had its IPO on under the ticker symbol SHREEGANES.

The company operates in the sector and industry. Shree Ganesh Biotech (India) Ltd has a staff strength of 0 employees.

Stock update

Shares of Shree Ganesh Biotech (India) Ltd opened at ₹0.99 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹0.91 - ₹1, and closed at ₹0.95.

This is a -3.06% slip from the previous day's closing price.

A total volume of 8,429,858 shares were traded at the close of the day’s session.

In the last one week, shares of Shree Ganesh Biotech (India) Ltd have slipped by -5%.

Shree Ganesh Biotech (India) Ltd's Key Ratios

Shree Ganesh Biotech (India) Ltd has a market cap of ₹20.73 million, indicating a price to book ratio of 1.0178 and a price to sales ratio of 0.7819.

In the last 12-months Shree Ganesh Biotech (India) Ltd’s revenue was ₹0 with a gross profit of ₹8.98 million and an EBITDA of ₹0. The EBITDA ratio measures Shree Ganesh Biotech (India) Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Shree Ganesh Biotech (India) Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, Shree Ganesh Biotech (India) Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Shree Ganesh Biotech (India) Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

43.3333

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shree Ganesh Biotech (India) Ltd’s profitability.

Shree Ganesh Biotech (India) Ltd stock is trading at a EV to sales ratio of 0.7649 and a EV to EBITDA ratio of 14.3008. Its price to sales ratio in the trailing 12-months stood at 0.7819.

Shree Ganesh Biotech (India) Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹716.45 million

Total Liabilities

₹89.78 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Shree Ganesh Biotech (India) Ltd ended 2024 with ₹716.45 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹716.45 million while shareholder equity stood at ₹626.67 million.

Shree Ganesh Biotech (India) Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹89.78 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹81000.00 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

Shree Ganesh Biotech (India) Ltd’s total current assets stands at ₹687.56 million while long-term investments were ₹0 and short-term investments were ₹13.81 million. Its net receivables were ₹129.31 million compared to accounts payable of ₹79.80 million and inventory worth ₹0.00.

In 2024, Shree Ganesh Biotech (India) Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Shree Ganesh Biotech (India) Ltd paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹0.95

52-Week High

₹3.5

52-Week Low

₹0.85

Analyst Target Price

₹

Shree Ganesh Biotech (India) Ltd stock is currently trading at ₹0.95 per share. It touched a 52-week high of ₹3.5 and a 52-week low of ₹3.5. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹1.03 and 200-day moving average was ₹1.18 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.